Neurol. praxi. 2018;19(5):387-388

Postavení nových antiepileptik v klinické praxi a jejich zaměnitelnost

prof. MUDr. Petr Marusič, Ph.D.
Neurologická klinika 2. LF UK a FN Motol, Praha

Published: October 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Marusič P. Postavení nových antiepileptik v klinické praxi a jejich zaměnitelnost. Neurol. praxi. 2018;19(5):387-388.
Download citation

References

  1. Brigo F, Bragazzi NL, Nardone R, Trinka E. Efficacy and tolerability of brivaracetam compared to lacosamide, eslicarbazepine acetate, and perampanel as adjunctive treatments in uncontrolled focal epilepsy: results of an indirect comparison meta-analysis of RCTs. Seizure. 2016; 42: 29-37. Go to original source...
  2. Brodie MJ, Sills GJ. Combining antiepileptic drugs - rational polytherapy? Seizure. 2011; 20(5): 369-375. Go to original source...
  3. Hovorka J. Farmakologická léčba epilepsie. Cesk Slov Neurol N 2010; 73/ 106(4): 351-373.
  4. Kolektiv autorů. Soubor minimálních diagnostických a terapeutických standardů u pacientů s epilepsií. EpiStop 2017.
  5. Luciano AL, Shorvon SD. Results of treatment changes in patients with apparently drugresistant chronic epilepsy. Ann Neurol. 2007; 62(4): 375-381. Go to original source...
  6. Mäkinen J, Rainesalo S, Raitanen J, Peltola J. The effect of newer antiepileptic drugs in combination therapy. Epilepsy Res. 2017; 132: 15-20. Go to original source...
  7. Marusič P, Vojtěch Z. Epilepsie. In: Štětkářová I. a kol. Moderní farmakologie v neurologii. 2. vydání. Maxdorf s.r.o., 2017: 42-78.
  8. Sake JK, Hebert D, Isojärvi J, Doty P, De Backer M, Davies K, Eggert-Formella A, Zackheim J. A pooled analysis of lacosamide clinical trial data grouped by mechanizms of action of concomitant antiepileptic drugs. CNS Drugs. 2010; 24: 1055-1068. Go to original source... Go to PubMed...
  9. Steinhoff BJ. Antikonvulsive Pharmakotherapie Jugendlicher und Erwachsener, State of the Art. Z Epileptol. 2013; 26: 142-153. Go to original source...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.